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THE study of intermediary metabolism in cultured mammalian cells has been
greatly facilitated by the development of chromatographic methods of separation
in conjunction with the availability of radioactively labelled substrates. Thus
considerable information about the metabolism and biosynthetic capacities of
long established cell cultures, such as HeLa cells, has been obtained in recent
years (Eagle, 1959 ; Levintow and Eagle, 1961). This paper is concerned with
a comparison of some aspects of intermediary metabolism of HeLa cells and a
more recently instituted cell culture, human foetal liver cells (Westwood, Mac-
Pherson and Titmuss, 1957). The incorporation ofradiocarbon from [14C]glucose,
[2-14C]acetate and [1: 4-14C2]succinate into the soluble metabolic intermediates
of both cell types was investigated. Although the qualitative patterns of incor-
poration ofradioactivity were similar it was found that there were some important
(liffereinces in the quantitative distribution of the isotope amongst the metabolic
intermediates.
'MATERIALS AND METHODS
Tissue culture cells
The HeLa and human foetal liver cells were a gift from Dr. D. E. Dewey of-
the British Empire Cancer Campaign Radiobiological Unit, Mount V1ernon
Hospital, Northwood, Middlesex. They were obtained as monolayer sheets ad-
herent to the lower surface of separate vessels, each of which contained about
10 ml. of incubation medium. The medium was decanted and replaced by
10 ml. of a solution, pH 7-4, containing 80 mg. of NaCl, 2 mg. of KCI, 12 mg. of
KH2PO4 and 2 mg. of versene (ethylenediamine tetra-acetic acid). The cells were
allowed to remain in contact with the versene solution for 30 minutes, being
gently shaken at intervals of 10 minutes, and the mixture centrifuged at 500 g
for 2 minutes. The supernatant was discarded and the cells suspended in 10 ml.
of a salt solution containing 90 mg. of NaCl, 3 mg. of KH2PO4, 3 mg. of CaC12
and 1 mg. of MgSO4 dissolved in distilled water and adjusted to pH 7-4. The
centrifugation and resuspension of the cells in 10 ml. of this salt solution were
repeated three times to remove protein and other material from the original
incubation medium. The cells were then suspended in 1 ml. of the salt solution,
counted in a haemocytometer and the final volume of cell suspension adjusted,.
as precisely as possible, to give a cell count of 12 x 106 cells per ml.INTERMEDIARY METABOLISM IN CELLS
Radioactive experiments
Samples (50 pl.) ofthe cellular suspensions were mixed with 50 ,ul. of a solutioin
containing 1 ,uc of either [14C]glucose, [2-'4C]acetate or [1: 4-'4C2]succinate and
incubated aerobically at 370 for 30 minutes with shaking. The radioactive sub-
strates were obtained from the Radiochemical Centre, Amersham, Bucks. At the
end of the incubation period the cells were killed by the addition of 400 /II. of
boiling ethanol and the mixtures centrifuged at 500 g to remove cellular debris.
The radioactive substances present in the supernatants were separated by two-
dimensional paper chromatography, visualised by radioautography and the l4
in each labelled intermediate counted by the techniques described by Smith and
Moses (1960). The radioactive spots on the chromatograms were identified pre-
sumptively by their chromatographic positions and this was confirmed by co-
chromatography with authentic materials in the same solvent systems.
RESULTS
Metabolism, of [14C]glucose.-The results given in Table I show that HeLa and
TABLE I.-J)istribution of Radioactivity from [4lk]Glucose in Soluble Inter-
mediates of HeLa and Foetal Liver Cells.
Results are expressed as counts per minute x 10-2
HeLa Foetal liver
Hexose phosphates 35 35
Lactate 69 15
Alanine 38 33
Aspartate 17
Glutamate 16 3
Percentage of glucose utilised . . 15 30
human foetal liver cells incorporated radioactivity from the labelled sugar inito
a number of intermediates known to be involved in established metabolic
sequences. The occurrence of 14C in the hexose phosphates and lactate is evidence
of the glycolytic pathway, and the presence of labelled amino acids shows the
presence of transamination reactions. The radioactive alanine was probably
formed from pyruvate, derived by glycolysis from the glucose carbons. How-
ever, the labelled aspartate and glutamate must have been produced by trans-
amination of their corresponding x-oxoacids, oxaloacetate and a-oxoglutarate,
showiing that glucose carbons entered the tricarboxylic acid cycle, presumably via
pyruvate and acetylcoenzyme A. The qualitative patterns of incorporation of
radiocarbon were similar for the two types of tissue culture cells but there was
some variation in the percentage utilisation of the radioactive substrate and in
the quantitative distribution of the isotope in the various fractions. While the
HeLa cells only utilised half as much labelled glucose they formed considerably
greater amounts of radioactive lactate, aspartate and glutamate thani the foetal
liver cells.
Metabolissm of [2-4'C]acetate. Table II shows that both cell types were capable
of metabolising the radioactive acetate but much smaller amounts of radiocarbon
were found in the labelled intermediates than in the glucose experiments. The
radioactive acetate is labile during chromatography and it was not possible to
measure the percentage utilisation of this labelled substrate. The qualitative
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TABLE II. Distribution of Radioactivityfrom [2-14C]Acetate in the Sotuble
Intermediates of HeLa and Foetal Liver Cells.
Results are expressed as counts per minute x 10-2
HeLa Foetal liver
Phosphates . 13 13
Lactate . . 19 86
Alanine . 2- 5 29
Aspartate 1-6 1*6
Glutamate 23 . 28
Malate . . 1-6 . 11
Citrate 0 3 . 4-1
patterns of incorporation of isotope were similar in the HeLa and foetal liver cells
and indicated that the acetate had been converted via acetylcoenzyme A and
pyruvate to lactate, alanine and phosphates; also that acetate carbons had
entered the tricarboxylic acid cycle and become incorporated into malate, citrate,
aspartate and glutamate. The foetal liver cells differed from the HeLa cells in
forming much greater amouints of radioactive citrate and lactate.
Blietabolism of [1: 4-14C2]succinate. The labelled succinate experiments (Table
III) show that less than 10 per cent of this substrate was utilised by both cell
TABLE III.-Distribution of Radioactivity from [1: 4_14C2]Succinate in the Soluble
Intermediates of HeLa and Foetal Liver Cells.
Results are expressed as counts per minute x 10-2
HeLa Foetal liver
Fumarate . 8 . 6
Malate 28 . 4
Citrate 6 . 19
Aspartate . . 3 . 1
Glutamate . 1 1
Glutamine 2 . 2
Percentage of succinate utilised 8 . 8
types and that radiocarbon was transferred around the tricarboxylic acid cycle
to fumarate, malate and citrate and incorporated into the amino acids, aspartate
and glutamate, associated with the cycle. The presence of radioactive glutamine
indicated that the cells possess glutamine synthetase activity. The foetal liver
cells incorporated more radiocarbon into citrate and less into malate than the
HeLa cells.
DISCUSSION
The results show that HeLa and human foetal liver cells incorporate measur-
able amounts ofradioactivity from [14C]glucose, [2_14C]acetate and [1: 4-14C2]suc-
cinate into a variety of metabolic intermediates. The patterns of incorporation
of the radiocarbon show the presence of several established metabolic pathways
in both types of cultured cell. The conversion of the labelled glucose into a
hexose phosphate fraction and into lactate (Table I) agrees with the findings of
other workers (Berenblum, Chain and Heatley, 1939; Pomerat and Willmer,
1949; Barting and Jones, 1954) that tissue culture cells possess an active glyco-
lytic system. The labelled acetate patterns (Table II) show that HeLa and foetal
liver cells are capable of converting acetate into acetylcoenzyme A and subse-INTERMEDIARY METABOLISM IN CELLS
quently forming a phosphate fraction, lactate and alanine; presumably via
pyruvate. Thus an acetate-activating enzyme system is present in both cell
types although it has been reported absent in sonically disintegrated preparations
from HeLa cells (Barban and Schulze, 1956). The present results (Tables II
and III) also provide evidence that both HeLa and foetal liver cells are capable
of metabolising acetate and succinate carbons by the tricarboxylic acid cycle,
and Barban and Schulze (1956) have shown that extracts of HeLa cells contain
all the enzyme systems associated with the cycle.
It has been stated that every human cell culture, whether normal or malignant
in origin, requires at least 13 amino acids for survival and growth. Of the amino
acids which are nutritionally non-essential, the carbon skeleton of alanine was
reported to be derived primarily from glucose while aspartate and glutamate
derived their carbon primarily from glutamine (Eagle, 1959). The present work
(Tables II and III) shows that glucose and acetate may provide the carbon
skeletons of alanine, aspartate and glutamate in the HeLa and foetal liver cells.
More radioactivity from the labelled glucose was incorporated into alanine,
especially by the foetal liver cells, but the acetate carbons were distributed much
more evenly between the three amino-acids. The failure to detect isotopically
labelled alanine or lactate in the succinate experiments (Table III) suggested
that both cell types are unable to form pyruvate from either malate or oxalo-
acetate, although Barban and Schulze (1956) reported that extracts of HeLa cells
contained malic enzyme activity. It therefore appears that the relative con-
tribution of a labelled substrate to the carbon skeleton of a particular amino
acid in cultured cells will depend on two factors. The first is the presence of the
appropriate enzyme systems and the second, the proximity in the metabolic
sequences of the labelled substrate to the amino acid. It is therefore not sur-
prising that glucose carbons are preferentially incorporated into alanine, and
glutamine carbons into glutamate and aspartate, as both these factors are in-
volved. The presence of labelled glutamine in the succinate experiments (Table
III) showed that both cell types contained glutamine synthetase activity. It
has been reported (Eagle, 1959) that mammalian cell cultures possess a limited
capacity to form glutamine from glutamate and ammonia. Levintow and
Eagle (1961) stated there was no evidence for the synthesis of glutamine from
more remote precursors, but the present results show that succinate may provide
part of the carbon skeleton of the amide.
Although the qualitative patterns ofincorporation ofisotope from the labelled
substrates into the soluble metabolic intermediates were similar for both HeLa
and foetal liver cells there were some interesting quantitative differences. The
HeLa cells utilised less of the labelled glucose but incorporated more radiocarbon
into lactate, aspartate and glutamate (Table I). These results show that the
foetal liver cells are able to metabolise glucose carbons to a greater extent than
HeLa cells. One possible mechanism is that the foetal liver cells oxidise a greater
proportion of glucose to carbon dioxide. However, the relative accumulation of
radioactive citrate in the acetate and succinate experiments (Tables II and III)
by the foetal liver cells suggests that the tricarboxylic acid cycle is less efficient
than in the HeLa cells. An alternative explanation is that the foetal liver cells
incorporated more isotope from the labelled glucose into insoluble materials, such
as glycogen and protein, which were not measured in the present work. This
may also account for the small amounts of radioactive aspartate and glutamate
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formed from the labelled glucose by the foetal liver cells, since Eagle (1959) has
also shown that cultured human cells incorporate the carbon skeleton of amino
acids, formed from [14C]glucose. directly into protein.
The two cell types also differed in the incorporation of radiocarbon from the
labelled succinate into malate and citrate (Table III). HeLa cells formed more
radioactive malate and less citrate than the foetal liver cells. The relative
accumulation of labelled malate in the HeLa cells suggests that they are less
efficient than the foetal liver cells in the further metabolism of malate. The in-
creased incorporations of radiocarbon in citrate by the foetal liver cells in both
the acetate (Table II) and the succinate experiments (Table III) may be related
to the relatively high content of citrate found by Dickens (1941) in some types
of cancerous tissue. This worker reported that tumour tissue usually contains
much citrate and that when the liver ofa rat bearing a Guerin tumour was analysed
simultaneously with the tumour, the liver had less than 1/5 of the citrate content
of the tumour. The presence of high endogenous pools of citrate in the foetal
liver cells could delay the metabolism of radioactive citrate by randomisation of
the labelled acid with the cold material.
SUMMARY
HeLa and human foetal liver cells in culture were found to incorporate radio-
activity from labelled substrates into a number of soluble metabolic intermediates
characteristic of glycolysis, the tricarboxylic acid cycle and transamination reac-
tions. The two cell types differed with respect to the quantitative distribution
of the radiocarbon amongst the radioactive intermediates formed.
We are grateful to Dr. D. E. Dewey for kindly providing the cultured cells.
This work was supported by a grant from the British Empire Cancer Campaign.
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